Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07478003Phase 3Recruiting

Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial

Role: lead

NCT02445885Not ApplicableRecruiting

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Role: lead

NCT04775914Not ApplicableRecruiting

STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance

Role: lead

NCT05462730Phase 2Completed

Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction

Role: lead

NCT03058627Not ApplicableActive Not Recruiting

Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation

Role: lead

All 5 trials loaded